• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for May 14, 2025

May 14, 2025
New hires and promotions in the med-tech industry, including: Ad Astra Diagnostics, Outset Medical, Segmed.
Read More

Financings for May 14, 2025

May 14, 2025
Med-tech firms raising money in public or private financings, including: CND Life Sciences.
Read More

Other news to note for May 14, 2025

May 14, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, Bruker, Cervos, Genoox, Median Technologies, Pager Health, Protera Health, Qiagen, Ranfac, Synchron, Telesair, Tri-anim Health.
Read More

Regulatory actions for May 14, 2025

May 14, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brightheart.
Read More

Today's news in brief

May 14, 2025
BioWorld MedTech briefs for May 14, 2025.
Read More

Regulatory actions for May 14, 2025

May 14, 2025
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beam, Hyundai, Regenxbio, Sarepta.
Read More

Other news to note for May 14, 2025

May 14, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abtherx, Affimed, AFT, Bayer, Endo, Galapagos, Hyloris, Intron, Leap, Mallinckrodt, Qliniq, Single Cell, Vaccinex.
Read More

In the clinic for May 14, 2025

May 14, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascendis, Atea, Biorestorative, Cytodyn, Cytokinetics, Enterobiotix, Iteos, Karyopharm, Mediwound, Novo Nordisk, Roche.
Read More

Financings for May 14, 2025

May 14, 2025
Biopharmas raising money in public or private financings, including: Altimmune, Axsome, Marvel, Neumora, Omeros, Remedy Plan, Sangamo, Stylus.
Read More

Appointments and advancements for May 14, 2025

May 14, 2025
New hires and promotions in the biopharma industry, including: Compugen, Eleva, Galapagos, Hansa, Orca Bio, Sonoma, Syndax.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 1551 1552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 14, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 14, 2025.
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 13, 2025
  • Digital globe illustrating pharma trade, tariffs

    Navigating the Trump tariffs: Biopharma execs weigh in

    BioWorld
    First quarter 2025 results presentations were the first chance analysts have had to quiz pharma companies in public about their exposure to the threat of U.S....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe